Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Authors
Keywords
-
Journal
THORAX
Volume -, Issue -, Pages thoraxjnl-2020-215266
Publisher
BMJ
Online
2021-02-12
DOI
10.1136/thoraxjnl-2020-215266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 Novel coronavirus: where we are and what we know
- (2020) Zhangkai J. Cheng et al. INFECTION
- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
- (2020) Sean McGrath et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
- (2020) Valentina Morena et al. European Journal of Internal Medicine
- COVID‐19 pneumonia treated with Sarilumab: a clinical series of eight patients
- (2020) Maurizio Benucci et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab for treatment of mechanically ventilated patients with COVID-19
- (2020) Emily C Somers et al. CLINICAL INFECTIOUS DISEASES
- Promising Effects of Tocilizumab in COVID-19: A Non-Controlled, Prospective Clinical Trial
- (2020) Farzaneh Dastan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
- (2020) Pranay Sinha et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
- (2020) Timothée Klopfenstein et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation
- (2020) Nicola Potere et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
- (2020) Lorenzo M. Canziani et al. JOURNAL OF AUTOIMMUNITY
- Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis
- (2020) Roberto Rossotti et al. JOURNAL OF INFECTION
- Use of the IL‐6R Antagonist Tocilizumab in Hospitalized COVID‐19 Patients
- (2020) Krish Patel et al. JOURNAL OF INTERNAL MEDICINE
- Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID‐19: a retrospective cohort study.
- (2020) Johannes Eimer et al. JOURNAL OF INTERNAL MEDICINE
- Efficacy of hydroxychloroquine and tocilizumab in patients with COVID-19: A single-center retrospective chart review (Preprint)
- (2020) Sohaib Roomi et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Early use of tocilizumab in the prevention of adult respiratory failure in SARS‐CoV‐2 infections and the utilization of interleukin‐6 levels in the management
- (2020) Suresh J. Antony et al. JOURNAL OF MEDICAL VIROLOGY
- Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID‐19
- (2020) Natasha N. Pettit et al. JOURNAL OF MEDICAL VIROLOGY
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
- (2020) Andrew Ip et al. PLoS One
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study
- (2020) G Rojas-Marte et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis
- (2020) László Márk Czumbel et al. Frontiers in Medicine
- Efficacy and safety of tocilizumab in COVID-19 patients
- (2020) Kai-Lian Zheng et al. Aging-US
- Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'
- (2020) Sonali Narain et al. CHEST
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- (2020) Francesco Perrone et al. Journal of Translational Medicine
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
- (2020) Malgorzata Mikulska et al. PLoS One
- Lack of tocilizumab effect on mortality in COVID19 patients
- (2020) Gregory E. Holt et al. Scientific Reports
- Observational study on off-label use of tocilizumab in patients with severe COVID-19
- (2020) Laetitia Albertini et al. European Journal of Hospital Pharmacy-Science and Practice
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study
- (2020) Benjamin Rossi et al. Pharmaceuticals
- COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia
- (2020) Garth W. Strohbehn et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
- (2020) Reza Malekzadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tocilizumab in hospitalized patients with COVID‐19: Clinical outcomes, inflammatory marker kinetics, and safety
- (2020) Joshua A. Hill et al. JOURNAL OF MEDICAL VIROLOGY
- Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
- (2020) A. Balkhair et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Use of the GRADE approach in systematic reviews and guidelines
- (2019) Anders Granholm et al. BRITISH JOURNAL OF ANAESTHESIA
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- An Improved Method for Simple, Assumption-Free Ordinal Analysis of the Modified Rankin Scale Using Generalized Odds Ratios
- (2014) Leonid Churilov et al. International Journal of Stroke
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started